Clinical Trial

Post Pandemic Pneumococcal Carriage Among Children and Adults

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 6, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
The PI propose to conduct a genomic epidemiology study of pneumococcal carriage among children and adults in a large metropolitan city. These data will allow PI to assess the post-pandemic population structure, investigate the phylogenetic relationship between isolates from children and adults, and compare pneumococcal populations across diverse geographic areas.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-15.
Status change: Not Yet Recruiting → Recruiting 2024-12-03
Trial Details
NCT Number NCT06373328
Lead Sponsor University of Central Florida
Collaborators: Merck Sharp & Dohme Corporation
Conditions Pneumococcal Carriage
Enrollment 900 participants
Start Date 2024-06-12
Primary Completion 2025-09 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2024-12-06